Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for In Utero Treatment of Congenital CMV Infection (CYMEVAL2)
NCT01651585Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2011
- Primary completion
- May 2015
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of valaciclovir in congenital cytomegalovirus infection (cCMV), sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2011; status: completed.
02
Drugs
valaciclovir
03
Conditions
congenital cytomegalovirus infection (cCMV)
Beyond the preview
Go deeper on NCT01651585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01651585.